Drug Shortage Report for VIOKACE

Last updated on 2019-08-13 History
Report ID 87801
Drug Identification Number 02230019
Brand name VIOKACE
Common or Proper name Viokace 10440
Company Name NESTLE ENTERPRISES S.A.
Market Status MARKETED
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 56400UNIT 57100UNIT 10440UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's bottle
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-07-12
Actual start date 2019-07-12
Estimated end date 2019-08-16
Actual end date 2019-08-12
Shortage status Resolved
Updated date 2019-08-13
Company comments Viokace 20880 remains in stock and available
Health Canada comments
Tier 3 Status No
Contact Address 12, RUE ENTRE-DEUX-VILLES
VEVEY, --
SWITZERLAND 1800
Company contact information kfeltmate@apcipharma.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-06-28 English Compare
v2 2019-06-28 French Compare
v3 2019-06-28 English Compare
v4 2019-06-28 French Compare
v5 2019-07-05 English Compare
v6 2019-07-05 French Compare
v7 2019-07-13 English Compare
v8 2019-08-07 English Compare
v9 2019-08-07 French Compare
v10 2019-08-12 English Compare
v11 2019-08-12 French Compare
v12 2019-08-13 English Compare

Showing 1 to 12 of 12